DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Norvir (Ritonavir) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (38)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Norvir (Ritonavir) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 38   Next >>

Possible Norvir side effects in male

Reported by a physician from Japan on 2012-08-24

Patient: male, weighing 59.5 kg (130.9 pounds)

Reactions: Pulmonary Hypertension, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Nausea, Tremor, Palpitations, Visual Impairment, Dizziness, Nervous System Disorder, Influenza Like Illness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Norvir
    Administration route: Oral
    Start date: 2008-09-20

Abacavir Sulfate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Stavudine
    Dosage: daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-08-25
    End date: 2001-10-20

Didanosine
    Administration route: Oral
    Start date: 2001-07-21
    End date: 2004-05-14

Saquinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-03-18

Norvir
    Administration route: Oral
    Start date: 2004-04-25
    End date: 2008-09-19

Efavirenz
    Administration route: Oral
    Start date: 2000-09-25
    End date: 2000-10-02

Didanosine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-11-19
    End date: 2001-07-21

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-12-24

Abacavir Sulfate
    Administration route: Oral
    Start date: 2001-10-20
    End date: 2001-10-27

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Lamivudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15
    End date: 2008-09-19

Saquinavir
    End date: 2001-03-31

Saquinavir
    Administration route: Oral
    Start date: 2000-05-24
    End date: 2000-12-24

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    End date: 2004-04-24

Indinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-08
    End date: 2000-05-24

Peginterferon Alfa-2B
    Indication: Hepatitis C
    Start date: 2002-08-17
    End date: 2003-07-12

Other drugs received by patient: Truvada; Amlodipine Besylate; Lexiva; Coagulation Factor Viii; Olmesartan Medoxomil; Tenofovir Disoproxil Fumarate; Isentress; Cross Eight M; Ribavirin; Coagulation Factor Viii; Ribavirin; Atazanavir



Possible Norvir side effects in 24 year old male

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: 24 year old male

Reactions: Pulmonary Hypertension, Palpitations, Dizziness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Videx EC
    Dosage: divided dose
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-21
    End date: 2004-05-14

Norvir
    Dosage: 31mar2001(interrupted).caps 800mg:19jun99-31oct-99.divided dose:01nov99-24dec2000.25apr2004
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2008-09-19

Ziagen
    Dosage: interrupted from 07/25/00 to 10/20/01 tabs24jul-25jul2000.20oct2001-27oct2001.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2001-10-27

Videx
    Dosage: 250,300,400mg12/19/94-3/7/97,3/07/97-7/21/01,7/21/01,125mg,19dc94-7mar97(810d),7mr97-21jl01(1598d)
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-12-19
    End date: 2001-07-21

Crixivan
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-18
    End date: 2000-05-24

Kaletra
    Dosage: 1df,25dec2000-24apr2004:1217 days
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2004-04-24

Invirase
    Dosage: inter:03/18/00-05/24/00,caps 800mg:19jun99-18mar2000.divided dse:24may00-24dec2000,19jun1999-24dc00
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2001-03-31

Efavirenz
    Dosage: interrupted from 07/25/00 to 09/25/00 24jul-25jul2000,25sep-02oct2000. film coated tab 200 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-10-02

Epivir
    Dosage: tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15
    End date: 2008-09-19

Zerit
    Dosage: 60 mg 8/25/97-27/2/98, 80 mg 2/27-8/3/98, 11/9/98 -6/19/99 and 12/25/00-10/20/01
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-08-25
    End date: 2001-10-20

Other drugs received by patient: Cross Eight M



Possible Norvir side effects in male

Reported by a physician from Italy on 2012-08-09

Patient: male

Reactions: Coronary Artery Occlusion

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ziagen
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Norvir
    Dosage: 100mg twice per day
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Prezista
    Dosage: 600mg twice per day
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Other drugs received by patient: Viread; Enalapril Maleate



Possible Norvir side effects in male

Reported by a physician from Italy on 2012-08-06

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Norvir
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Darunavir Ethanolate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Ziagen
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Other drugs received by patient: Enalapril Maleate; Viread; Chlorthalidone



Possible Norvir side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-02

Patient: male

Reactions: Adverse Event

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viread

Videx

Reyataz

Norvir



Possible Norvir side effects in male

Reported by a physician from Japan on 2012-08-02

Patient: male

Reactions: Salmonella Sepsis, Hepatic Function Abnormal, Castleman's Disease, Platelet Count Decreased, Rash

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Truvada
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-01-08

Truvada
    Dosage: 1 df, qd
    Administration route: Oral
    Start date: 2010-08-16

Prezista
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-01-08
    End date: 2010-01-21

Norvir
    Dosage: 100 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-01-08
    End date: 2010-01-21

Betamethasone
    Dosage: 1 df, tid
    Administration route: Oral
    Indication: Rash
    Start date: 2010-01-18
    End date: 2010-01-26

Truvada
    Dosage: 1 df, qd
    Administration route: Oral
    Start date: 2010-02-08
    End date: 2012-06-30

Betamethasone
    Dosage: 1 df, tid
    Administration route: Oral
    Start date: 2010-01-27
    End date: 2010-01-31

Other drugs received by patient: Efavirenz; Isentress; Epivir; Zerit; Loperamide Hydrochloride



Possible Norvir side effects in male

Reported by a physician from Italy on 2012-07-27

Patient: male

Reactions: Coronary Artery Occlusion, Arteriosclerosis Coronary Artery

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Prezista
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Norvir
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Ziagen
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Other drugs received by patient: Enalapril Maleate; Viread



Possible Norvir side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient:

Reactions: Brain Stem Haemorrhage, Pneumonia, Hypertension, Neuralgia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Epivir
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2005-11-11
    End date: 2006-07-14

Epivir
    Dosage: 50 mg, qd
    Administration route: Oral
    Start date: 2006-08-23
    End date: 2010-01-04

Isentress
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-09-24
    End date: 2010-01-04

Epivir
    Dosage: 150 mg, bid
    Administration route: Oral
    Start date: 2005-10-12
    End date: 2005-11-10

Prezista
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-09-24
    End date: 2010-01-04

Epivir
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2004-09-27
    End date: 2004-11-03

Epivir
    Dosage: divided dose frequency unknown
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-06
    End date: 2001-10-21

Norvir
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-02-16
    End date: 2005-06-08

Norvir
    Dosage: 100 mg, bid
    Administration route: Oral
    Start date: 2007-09-24
    End date: 2010-01-04

Other drugs received by patient: Zerit; Novact M; MS Contin



Possible Norvir side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-12

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Norvir
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Darunavir Hydrate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Ziagen
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Other drugs received by patient: Enalapril Maleate; Chlorthalidone; Viread



Possible Norvir side effects in male

Reported by a physician from Italy on 2012-07-05

Patient: male

Reactions: Coronary Artery Occlusion, Arteriosclerosis Coronary Artery

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ziagen
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Prezista
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Norvir
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Other drugs received by patient: Enalapril Maleate; Viread



Possible Norvir side effects in male

Reported by a physician from Italy on 2012-06-18

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ziagen
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Darunavir Hydrate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Norvir
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Other drugs received by patient: Viread; Chlorthalidone; Enalapril



Possible Norvir side effects in male

Reported by a physician from Italy on 2012-06-15

Patient: male

Reactions: Coronary Artery Occlusion

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Prezista
    Dosage: 600mg twice per day
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-10-30

Ziagen
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Norvir
    Dosage: 100mg twice per day
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Other drugs received by patient: Enalapril; Viread



Possible Norvir side effects in male

Reported by a physician from Italy on 2012-06-11

Patient: male

Reactions: Coronary Artery Occlusion, Arteriosclerosis Coronary Artery

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ziagen
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Norvir
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Prezista
    Administration route: Oral
    Indication: Acute HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Other drugs received by patient: Enalapril Maleate; Viread



Possible Norvir side effects in 46 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23

Patient: 46 year old male

Reactions: Haptoglobin Decreased, Pancytopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvir
    Administration route: Oral
    Indication: HIV Infection
    End date: 2012-02-01

Risperdal
    Administration route: Oral
    Start date: 2009-01-01
    End date: 2011-02-01

Ketek
    Administration route: Oral
    Start date: 2011-01-24
    End date: 2011-02-01

Other drugs received by patient: Atazanavir Sulfate; Corticosteroid NOS; Trimeprazine Tartrate; Emtricitabine / Tenofovir Disoproxil Fumarate; Valium; Desmopressin Acetate; Tazobactam; Bactrim



Possible Norvir side effects in 46 year old female

Reported by a physician from Switzerland on 2012-05-18

Patient: 46 year old female

Reactions: Confusional State, Mydriasis, Serotonin Syndrome, Hyperhidrosis, Tremor, Myoclonus, Fatigue, Dizziness, Hepatic Cirrhosis, Decreased Appetite

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Administration route: Oral
    Indication: Depression
    Start date: 2007-01-01
    End date: 2012-04-29

Truvada
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-25

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-04-25

Nexium
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2012-04-22

Prezista
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-04-25

Other drugs received by patient: Atovaquone; Fluticasone Propionate / Salmeterol; Nasonex; Lansoprazole; Spironolactone; Oxazepam; Importal; Noroxin; Torsemide; Morphine Sulfate; Rohypnol



Possible Norvir side effects in 46 year old female

Reported by a physician from Switzerland on 2012-05-14

Patient: 46 year old female

Reactions: Confusional State, Jaundice, Drug Level Increased, Chills, Drug Interaction, Serotonin Syndrome, Muscle Rigidity, Hyperhidrosis, Asterixis, Fatigue, Decreased Appetite, Hypertonia, Hepatic Pain, Mydriasis, Vomiting, Nausea, Tremor, Myoclonus, Psychomotor Skills Impaired, Vertigo

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Norvir

Other drugs received by patient possibly interacting with the suspect drug:
Prezista
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-04-25

Nexium
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2012-04-22

Escitalopram
    Administration route: Oral
    Indication: Depression
    Start date: 2007-01-01
    End date: 2012-04-29

Other drugs received by patient: Importal; Lansoprazole; Morphine Sulfate; Rohypnol; Aldactone; Oxazepam; Nasonex; Atovaquone; Noroxin; Fluticasone Propionate / Salmeterol; Truvada; Torsemide



Possible Norvir side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-02

Patient: 55 year old male, weighing 72.0 kg (158.4 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Viread
    Indication: HIV Infection
    Start date: 2006-10-30

Darunavir Hydrate
    Indication: HIV Infection
    Start date: 2006-10-30
    End date: 2011-12-23

Norvir
    Indication: HIV Infection
    Start date: 2006-10-30

Ziagen
    Indication: HIV Infection
    Start date: 2006-10-30

Other drugs received by patient: Enalapril; Chlorthalidone



Possible Norvir side effects in 41 year old male

Reported by a physician from Japan on 2012-03-28

Patient: 41 year old male

Reactions: Pancreatitis Acute, Death, Hyperlipidaemia, Hyperlactacidaemia, Amylase Increased, Neuropathy Peripheral, Diarrhoea, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Fosamprenavir Calcium
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-08-04

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-13
    End date: 2001-05-10

Epivir
    Dosage: therapy interrupted on 09-jan-2000, discontinued on 06-jul-2001.
    Administration route: Oral
    Start date: 1996-10-01
    End date: 2001-07-06

Saquinavir Mesylate
    Indication: HIV Infection
    Start date: 2001-01-05
    End date: 2001-03-08

Ziagen
    Dosage: therapy interrupted from 08-dec-2000 to 05-jun-2001
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-24
    End date: 2001-07-06

Somatropin
    Indication: Weight Decreased
    Start date: 2001-03-19
    End date: 2001-11-12

Raltegravir
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2008-09-26

Zerit
    Dosage: ongoing 01-aug-1995 to 01-mar-1996 and 01-apr-1998 to 08-dec-2000.
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1995-08-01
    End date: 2000-12-08

Efavirenz
    Dosage: therapy interp 12/8/00,restarted 3/9/01,interrupt7/01,+restarted 7/23/01-25sep8(2622 days)
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-10
    End date: 2008-09-25

Prezista
    Dosage: tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26

Videx
    Dosage: ongoing 01/sept/1993 - 01/aug/1994; 01/mar/1996 - 01/oct/1996; and 10/jan/2000 - 08/dec/2000
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1993-09-01
    End date: 2000-12-08

Truvada
    Dosage: 1 df = 1 tablet
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26
    End date: 2009-10-01

Kaletra
    Dosage: 8 caps 9mar-6jul01, restarted 23jul01 stopped 4oct6 reduced to 6 tabs from 05oct6-15sep8 (1900 days)
    Indication: HIV Infection
    Start date: 2001-03-09
    End date: 2008-09-25

Norvir
    Dosage: 05jan01 to 04feb01, 05feb01 to 08mar01 and 26sep08 to ongoing.
    Indication: HIV Infection
    Start date: 2001-01-05

Amprenavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-23
    End date: 2005-08-03

Other drugs received by patient: Retrovir; Viracept; Recombinate; Loperamide HCL; Crixivan; Octocog Alpha; Loperamide HCL; OIF



Possible Norvir side effects in 71 year old male

Reported by a pharmacist from Germany on 2012-02-28

Patient: 71 year old male, weighing 81.0 kg (178.2 pounds)

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 1df:300 unit no reyataz 150
    Administration route: Oral
    Indication: HIV Infection

Norvir
    Dosage: 1df:100 unit nos
    Administration route: Oral
    Indication: HIV Infection

Abacavir Sulfate / Lamivudine
    Dosage: 1df:600/300 unit nos
    Administration route: Oral
    Indication: HIV Infection

Other drugs received by patient: Aspirin; Ramipril; Fentanyl; Metoprolol Tartrate; Gabapentin; Norepinephrine Bitartrate; Doxazosin; Hydrochlorothiazide; Esomeprazole Sodium; Torsemide; Zopiclone; Midazolam; Linezolid; Propofol



Possible Norvir side effects in 41 year old male

Reported by a physician from Japan on 2012-02-20

Patient: 41 year old male

Reactions: Pancreatitis Acute, Death, Hyperlipidaemia, Hyperlactacidaemia, Amylase Increased, Neuropathy Peripheral, Diarrhoea, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Zerit
    Dosage: ongoing 01-aug-1995 to 01-mar-1996 and 01-apr-1998 to 08-dec-2000.
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1995-08-01
    End date: 2000-12-08

Videx
    Dosage: ongoing 01/sept/1993 - 01/aug/1994; 01/mar/1996 - 01/oct/1996; and 10/jan/2000 - 08/dec/2000
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1993-09-01
    End date: 2000-12-08

Efavirenz
    Dosage: therapy interp 12/8/00,restarted 3/9/01,interrupt7/01,+restarted 7/23/01-25sep8(2622 days)
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-10
    End date: 2008-09-25

Ziagen
    Dosage: therapy interrupted from 08-dec-2000 to 05-jun-2001
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-24
    End date: 2001-07-06

Somatropin Rdna
    Indication: Weight Decreased
    Start date: 2001-03-19
    End date: 2001-11-12

Norvir
    Dosage: 05jan01 to 04feb01, 05feb01 to 08mar01 and 26sep08 to ongoing.
    Indication: HIV Infection
    Start date: 2001-01-05

Kaletra
    Dosage: 8 caps 9mar-6jul01, restarted 23jul01 stopped 4oct6 reduced to 6 tabs from 05oct6-15sep8 (1900 days)
    Indication: HIV Infection
    Start date: 2001-03-09
    End date: 2008-09-25

Fosamprenavir Calcium
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-08-04

Prezista
    Dosage: tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26

Raltegravir
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2008-09-26

Amprenavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-23
    End date: 2005-08-03

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-13
    End date: 2001-05-10

Epivir
    Dosage: therapy interrupted on 09-jan-2000, discontinued on 06-jul-2001.
    Administration route: Oral
    Start date: 1996-10-01
    End date: 2001-07-06

Truvada
    Dosage: 1 df = 1 tablet
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26
    End date: 2009-10-01

Saquinavir Mesylate
    Indication: HIV Infection
    Start date: 2001-01-05
    End date: 2001-03-08

Other drugs received by patient: OIF; Loperamide HCL; Retrovir; Crixivan; Viracept; Recombinate; Loperamide HCL



Possible Norvir side effects in 57 year old female

Reported by a physician from United Kingdom on 2012-02-16

Patient: 57 year old female, weighing 37.0 kg (81.4 pounds)

Reactions: Mitochondrial Cytopathy

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-12-19
    End date: 2012-01-05

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-12-19
    End date: 2012-01-05

Darunavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-12-19
    End date: 2012-01-05

Other drugs received by patient: Lactate; Cotrim; Dextrose; Lactate



Possible Norvir side effects in 57 year old female

Reported by a physician from United Kingdom on 2012-02-09

Patient: 57 year old female, weighing 37.0 kg (81.4 pounds)

Reactions: Mitochondrial Cytopathy

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-12-19
    End date: 2012-01-05

Darunavir Ethanolate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-12-19
    End date: 2012-01-05

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-12-19
    End date: 2012-01-05

Other drugs received by patient: Cotrim



Possible Norvir side effects in male

Reported by a physician from United States on 2012-02-06

Patient: male

Reactions: Abdominal Pain, Hepatic Function Abnormal, Hepatitis C, Hyperthermia, Pyrexia, Oesophageal Varices Haemorrhage, Gastritis, Intestinal Mucosal Hypertrophy, Liver Function Test Abnormal, Erosive Oesophagitis, Erosive Duodenitis, Lipoatrophy, Hepatic Cirrhosis, Hepatosplenomegaly, Nausea, Anastomotic Haemorrhage, Ascites, Haemoglobin Decreased, Haematochezia, Staphylococcal Infection, Arthralgia, Arthritis Bacterial, Gastroenteritis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamivudine
    Administration route: Oral
    Start date: 2005-04-01
    End date: 2005-04-24

Lamivudine
    Administration route: Oral
    Start date: 1997-12-29
    End date: 2005-04-24

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Stavudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-27

Reyataz
    Administration route: Oral
    Start date: 2004-07-30
    End date: 2005-04-24

Norvir
    Administration route: Oral
    Start date: 2008-07-14

Lamivudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Truvada
    Start date: 2005-05-24

Other drugs received by patient: Emtricitabine and Tenofovir Disoproxil Fumarate; Glycine; Coagulation Factor Viii; Tenofovir Disoproxil Fumarate; Cysteine; Octocog Alfa; Glycyrrhisinic Acid; Ammonium Glycyrrhizinate; Ammonium Glycyrrhizinate



Possible Norvir side effects in 31 year old male

Reported by a consumer/non-health professional from United States on 2012-02-01

Patient: 31 year old male

Reactions: Liver Function Test Abnormal, Arthritis Bacterial, Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Efavirenz
    Dosage: therapy start date: 25-apr-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Truvada
    Dosage: tabs; therapy start date: 24-may-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-05-24

Norvir
    Dosage: cap.also norvir soft 100mg 1day on 14jul08-unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Lamivudine
    Dosage: 150 mg on 29dec97-24may05 300(1day) mg on 25apr05-23may05.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Viread
    Dosage: tab.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Reyataz
    Dosage: divided dose frequency u.also 300mg per 1d on 28jul04-24may05.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-27

Other drugs received by patient: Rabeprazole Sodium; Cysteine; Glycyrrhizinic Acid; Glycine; Kogenate; Octocog Alpha; Ammonium Glycyrrhizinate



Possible Norvir side effects in 39 year old male

Reported by a consumer/non-health professional from Japan on 2012-01-27

Patient: 39 year old male

Reactions: Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: 30jan04-27jul04 400 mg (180days). 28jul04-24apr05 300 mg.cap
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2005-04-24

Epivir
    Dosage: also 300mg on 25apr2005-23may2005.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Norvir
    Dosage: 28jul04-24apr05: 271 days 14jul08-cont.cap. norvir soft
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28

Viread
    Dosage: tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Other drugs received by patient: NEO-Minophagen C; Kogenate; Antihemophilic Factor (Human)



Possible Norvir side effects in 31 year old male

Reported by a physician from United States on 2012-01-27

Patient: 31 year old male

Reactions: Liver Function Test Abnormal, Arthritis Bacterial, Hepatic Cirrhosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Efavirenz
    Dosage: therapy start date: 25-apr-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2008-07-13

Reyataz
    Dosage: divided dose frequency u.also 300mg per 1d on 28jul04-24may05.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-30
    End date: 2004-07-27

Viread
    Dosage: tab.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-25
    End date: 2005-05-23

Norvir
    Dosage: cap.also norvir soft 100mg 1day on 14jul08-unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-07-28
    End date: 2005-04-24

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-21
    End date: 2005-04-24

Lamivudine
    Dosage: 150 mg on 29dec97-24may05 300(1day) mg on 25apr05-23may05.tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-12-29
    End date: 2005-05-23

Truvada
    Dosage: tabs; therapy start date: 24-may-2005
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-05-24

Other drugs received by patient: Ammonium Glycyrrhizinate; Kogenate; Octocog Alpha; Rabeprazole Sodium; Glycine; Glycyrrhizinic Acid; Cysteine



Possible Norvir side effects in 44 year old female

Reported by a consumer/non-health professional from Germany on 2012-01-27

Patient: 44 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz
    Dosage: cumulative dose of reyataz to first adverse reaction 32700 mg
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2011-04-20
    End date: 2011-08-19

Cotrim DS
    Dosage: cumulative dose of cotrim forte to 1st adverse reaction was 58 x 0.5 tabs 1df:0.5tab
    Administration route: Oral
    Start date: 2011-04-13
    End date: 2011-08-19

Norvir
    Dosage: (dosage form 82). the cumulative dose of norvir to the first adverse reaction was 10900 mg.
    Administration route: Oral
    Start date: 2011-04-20

Truvada
    End date: 2011-07-28

Abacavir Sulfate
    Dosage: tabs 1df=82-units nos cumulative dose of kivexa to 1st adverse reaction was 9 tabs
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2011-07-29
    End date: 2011-08-19

Other drugs received by patient: Citalopram Hydrobromide; Ramipril; Bisoprolol Fumarate; Adalat; Fluconazole



Possible Norvir side effects in 27 year old male

Reported by a physician from Poland on 2011-12-28

Patient: 27 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Blood Creatine Phosphokinase Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Darunavir Ethanolate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-06-20
    End date: 2011-12-04

Raltegravir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-06-20
    End date: 2011-12-04

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-06-20
    End date: 2011-12-04



Possible Norvir side effects in 27 year old male

Reported by a physician from Poland on 2011-12-22

Patient: 27 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Blood Creatine Phosphokinase Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-06-20
    End date: 2011-12-04

Raltegravir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-06-20
    End date: 2011-12-04

Darunavir Ethanolate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-06-20
    End date: 2011-12-04



Possible Norvir side effects in male

Reported by a physician from Japan on 2011-12-13

Patient: male

Reactions: Pulmonary Hypertension, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Nausea, Tremor, Palpitations, Visual Impairment, Nervous System Disorder, Dizziness, Influenza Like Illness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Stavudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-04-01
    End date: 2001-10-20

Lamivudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15
    End date: 2008-09-19

Saquinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-03-18

Norvir
    Administration route: Oral
    Start date: 2004-04-25
    End date: 2008-09-19

Efavirenz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-12-24

Indinivir Sulfate
    Indication: HIV Infection
    Start date: 2000-03-08
    End date: 2000-05-24

Peginterferon Alfa-2B
    Indication: Hepatitis C
    Start date: 2002-08-17
    End date: 2003-07-12

Didanosine
    Administration route: Oral
    Start date: 2001-07-21
    End date: 2004-05-14

Abacavir Sulfate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Abacavir Sulfate
    Administration route: Oral
    Start date: 2001-10-20
    End date: 2001-10-27

Efavirenz
    Administration route: Oral
    Start date: 2000-09-25
    End date: 2000-10-02

Didanosine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-11-19
    End date: 2001-07-21

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    End date: 2004-04-24

Norvir
    Administration route: Oral
    Start date: 2008-09-20

Saquinavir
    Administration route: Oral
    Start date: 2000-05-24
    End date: 2000-12-24

Other drugs received by patient: Ribavirin; Isentress; Amlodipine Besylate; Coagulation Factor Viii; Lexiva; Olmesartan Medoxomil; Tenofovir; Coagulation Factor Viii; Ribavirin; Atazanavir; Truvada



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017